Dr. Reddy's Laboratories share news, announcements and annual reports
NSE: DRREDDYBSE: 500124Pharmaceuticals & BiotechnologyMid Cap
Dr. Reddy's Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1986 on BSE, May 2003 on NSE
Last close ₹1,352.00up ₹7.00 (0.52%)BSE ₹1,350.20
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,345.00.
30 Oct: open ₹1,345.00, high ₹1,363.70, low ₹1,345.00
52-week range of traded prices to 30 Oct 2026
₹1,101.00Low, 23 Jul 2026₹1,414.90High, 29 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,12,849 Cr104th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.30
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.59%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,14,05957.9% delivered
Dr. Reddy's Laboratories shareholder meetings
57 filed, newest first. Page 1 of 2.
Jul 2026
Jun 2026
Jul 2025
Jun 2025
Sep 2024
Aug 2024
Jul 2024
May 2024
Feb 2024
Jan 2024
Nov 2023
Oct 2023
Jul 2023
Oct 2022
Sep 2022
Jul 2022
Mar 2022
Feb 2022
Jul 2021
Jul 2020
Jan 2020
Dec 2019
Jul 2019
Jun 2019
Mar 2019
Jul 2018
Jun 2018
Jan 2018
Jul 2017
Jun 2017
Jul 2016
Jun 2016
Mar 2016
Sep 2015
Aug 2015
Jul 2015
Jun 2015
Jun 2014
May 2013
20 May · Meeting
Dr. Reddy's Laboratories Limited has informed the Exchange that the Company has fixed Book Closure from July 16, 2013 to July 19, 2013 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determing the sharehoders who would be entitled for the payment of dividend if declared at the forthcoming Annual General Meeting, scheduled to be held on July 31, 2013.
Jul 2012
Jun 2012
6 Jun · Meeting
Dr. Reddy'S Laboratories Limited has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 03, 2012 to July 06, 2012 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 20, 2012.
Jul 2011
Jun 2011
14 Jun · Meeting
Dr. Reddy'S Laboratories Limited has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 05, 2011 to July 09, 2011 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 21, 2011.
Jul 2010
Jun 2010
10 Jun · Meeting
Dr. Reddy'S Laboratories Limited has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 6, 2010 to July 10, 2010 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 23, 2010.
Aug 2009
26 Aug · Meeting
Dr. Reddy's Laboratories Ltd. has submitted to the Exchange a copy of the minutes of the proceedings of the Annual General Meeting of the company held on July 22, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.